Preview

Obstetrics, Gynecology and Reproduction

Advanced search

BREAST CANCER AND PREGNANCY

https://doi.org/10.17749/2313-7347.2017.11.1.074-080

Full Text:

Abstract

25 evidenced based clinical practice guidelines for fertility preservation in cancer patients exist. Breast Cancer in Pregnancy is a rare problem but the incidence is growing, because pregnancy will be delayed in elder age groups. Diagnosis of Breast Cancer is often delayed. If there is a mass, you have to do at first an ultrasound and than mammography if it is necessary. A tumor should be biopsied. Each kind of surgery is possible. Sentinel lymphnode dissection is controversial discussed. It is because of the blue dye, because this substance is not allowed during pregnancy. Technetium is allowed, but will be not accepted by the mother, because of fear of radiance. Radiation and hormonal treatment should be postponed after pregnancy. Chemotherapy can be done after 16 week of gestation. Delivery should not be in the first 3 weeks after chemotherapy, because the nadir of white blood cells should not be at the time of delivery to avoid infection. The fetal outcome is quite normal except weight, because of preterm delivery and growth retardation. Termination of pregnancy will not optimize the cancer prognosis. Pregnancy after breast cancer treatment is possible, perhaps with better prognosis, but that can be due to the healthy mother effect. Because the most recurrence are in the first two years, women should wait 2 years and cryopreservation of ovarian tissue, eggs or embryos before chemotherapy should be done.

About the Authors

Ch. Dadak
Medical University of Vienna
Austria

MD, Professor, University Clinic of obstetrics and gynecology, Center for teaching International postgraduate training in women's health. Address: AKH, Wдhringer Gьrtel 18-20/8C 1090 Vienna, Austria. Tel.: +43140400/29100; fax: +4314040027750



A. D. Makatsariya
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation

MD, corresponding member of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics and Gynecology, Faculty of Medical and Preventive, I.M. Sechenov First Moscow State Medical University. Address: ul. Trubetskaya, 8, str. 2, Moskva, Russia, 119048. Tel.: +7(495)7885840



References

1. Ventura S.J. First birth to older mother 1970-86. Am J Public Health. 1989; 79 (12): 1675-1677.

2. Woo J.C., Yu T., Huvud T.C. Breast Cancer in Pregnancy: a literature review. Breast J. 2016; 22 (6): 657-661. Arch surg. 2003; 138-91.

3. Loibl S., Minkwitz G., Groyn K. et al. Breast Carcinoma during pregnancy. Cancer. 2006; 106 (2): 237-246.

4. Nettleton J., Long J., Kuban D. et al. Breast Cancer during pregnancy: quantifying the risk of treatment delay. Obstet Gynecol. 1996; 87: 414.5.

5. Navrozoglou I., Vrekoussis T., Kontostolis E. et al. Breast cancer during pregnancy : a mini- review. Eur J Surg Oncol. 2008; 34: 837-43.

6. Ishida T., Yokoe T., Kasumi F. et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res. 1992; 83: 1143-49.

7. Goldsmith H.S. Milk-rejection sign of breast cancer. Am J Surg. 1974; 27: 280.

8. Middleton L.P., Anim M., Gwyn K., Theriaulr R., Satim A. Breast Carcinoma in pregnant women. Cancer. 2003; 98 (859) 1055-1060.

9. Amant F., Deckers S., Van Calsteren K. et al. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010; 46: 3158-3168.

10. Hahn K.M., Johnson P.H., Gordon N. et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107: 1219 -1226.

11. Cardonick E., Dougherty R., Grana G., Gilmandyar D., Ghaffar S., Usmani A. Breast Cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010; 16: 76-82.

12. Dominici L.S., Kuerer H.M., Babiera G. et al. Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis. 2010; 31: 1-5.

13. Stensheim H., Moller B. van Dijk T., Fossa S.D. Cause-specific survival for women diagnosed with Cancer during pregnancy or lactation: a registry- based cohort study. J Clin Oncol. 2009; 27: 45-51.

14. Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004; 5: 283.

15. Mir O., Berveiller P., Goffinet F. et al. Taxanes for breast cancer during pregnancy: a systematic rewiew. Ann Oncol. 2010; 21: 425-26.

16. Williams S.F., Schilsky R.L. Antineoplastic drugs administered during pregnancy. Semin Oncol. 2000; 27: 618-622.

17. Azim H.A. Jr., Azim H., Peccatori F.A. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev. Clin Immunol. 2010; 6: 821-26.

18. Cullins S.L., Pridjian G., Sutherland C.M. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation. JAMA. 1994; 271: 1905.

19. Isaacs R.J., Hunter W., Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy-case report and literature review. Gynecol Oncol. 2001; 80: 405- 408.

20. Ardalan A., Bungum T. Gestational age and the risk of maternal breast cancer: A population based Case Control Study. Breast J. 2016; 22 (6) 657-661.

21. Pavlidis N., Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res. 2008; 178: 183-94.

22. Loibl S., Han S.N., von Minckwitz G., Bontenbal M., Ring A., Giermek J., Fehm T., Van Calsteren S.C., Schlehe B., Gziri M.M., Westenend P.J., Mьller V., Heyns L., Rack B., Van Calster B., Harbeck N., Lenhard M., Halaska M.J., Kaufmann M., Nekljudova V., Amant F. Treatment of breast cancer during pregnancy:.an observational study. Lancet Oncol. 2012 ; 13 (9): 887-896.

23. Amant F., Vandenbroucke T., Verheecke M. et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2015; 373: 1824.

24. Vandenbroucke T., Van Calsteren K., Amant F. Pediatric outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2016; 374 (7) 693.

25. Aviles A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001; 2: 173-77.

26. Amant F., von Minckwitz G., Han S.N. et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013; 31: 2532.

27. Litton J.K., Warneke C.L., Hahn K.M. et al. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist. 2013; 18: 369.

28. Azim H.A. jr., Santorz L., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A. Prognosis of PABC: A meta-analysis of 30 studies. Cancer treatment Reviews. 2012; 38 (7): 834-842.

29. Loibl S., Han S.N. von Minckwitz et al. Treatment of breast cancer during pregnancy: an observational study. Jama Oncol. 2015; 1 (8) 1145-1153.

30. Cardonick E.H. Overview of infertility and pregnancy outcome in cancer survivors up to date 2014.

31. Azim H.A. Jr., Santoro L., Pavlidis N. et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011; 47: 74.

32. Loibl S., Kohl J., Kaufmann M. Reproduction after breast Cancer. Zentrallblatt Gynekol. 2005; 127 (3): 120-124.

33. Lee S.J., Schover L.R., Partridge A.H. et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006; 24: 2917.

34. Gadducci A., Cosio S., Genazzani A.R. Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endokrinol. 2007; 23 (11): 625-631.

35. Tulandi T., Huang J.Y., Tan S.L. Preservation of female Fertility: An Essential Progress. Obstet Gynecol. 2008; 5: 1160-1172.

36. D’Agostino N.M., Edelstein K. Psychosocial challenges and resource need of young adult cancer survivors: implications for program development. J Psychosoc Oncol. 2013; 31: 585.

37. Font-Gonzales A., Mulder R.L., Loeffen E.A. et al. Fertility preservation in children, adolescents and Young Adults with cancer: Reality of clinical practice guidelines and variations in recommendations. Cancer. 2016; 122: 2216-2223.

38. Ruddy K.J., Gelber S.I., Tamimi R.M. et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014; 32: 1151.

39. Morrow P.K., Broxson A.C., Munsell M.F. et al. Effect of age and race on quality of life in young breast cancer survivors. Clin Breast Cancer. 2014; 14: e21.

40. Barthelmes L., Davidson L.A., Gaffney C., Gateley C.A. Pregnancy and Breast cancer. BMJ. 2005; 330: 1375-1378


For citation:


Dadak C., Makatsariya A.D. BREAST CANCER AND PREGNANCY. Obstetrics, Gynecology and Reproduction. 2017;11(1):74-80. https://doi.org/10.17749/2313-7347.2017.11.1.074-080

Views: 173


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)